Publications and Citation History
Publications based on Top Specialties
Types of Publication
- Publications
- Books
- Patents
- NIH/NSF
Add
Delete
|
---|
Molecular Cancer Therapeutics, volume 20, issue 2, pages 340-346 (2021). |
Patent Number: 10639378 (2020) |
Patent Number: 10544218 (2020) |
Patent Number: 10494432 (2019) |
Evaluation and use of an anti‐cynomolgus monkey CD79b surrogate antibody–drug conjugate to enable clinical development of polatuzumab vedotin (journal article) British Journal of Pharmacology, volume 176, issue 19, pages 3805-3818 (2019). |
Clinical Cancer Research, volume 25, issue 4, pages 1358-1368 (2019). |
Preclinical pharmacokinetics and pharmacodynamics of DCLL9718A: An antibody-drug conjugate for the treatment of acute myeloid leukemia (journal article) mAbs, volume 10, issue 8, pages 1312-1321 (2018). |
mAbs, volume 10, issue 5, pages 738-750 (2018). |
Patent Number: 9896506 (2018) |
Patent Number: 9845355 (2017) |
Patent Number: 20170348422 (2017) |
Stabilizing a Tubulysin Antibody–Drug Conjugate To Enable Activity Against Multidrug-Resistant Tumors (journal article) ACS Medicinal Chemistry Letters, volume 8, issue 10, pages 1037-1041 (2017). |
Anti‐CD22 and anti‐CD79b antibody‐drug conjugates preferentially target proliferating B cells (journal article) British Journal of Pharmacology, volume 174, issue 8, pages 628-640 (2017). |
Patent Number: 9360484 (2016) |
A Novel Anti-CD22 Anthracycline-Based Antibody–Drug Conjugate (ADC) That Overcomes Resistance to Auristatin-Based ADCs (journal article) Clinical Cancer Research, volume 21, issue 14, pages 3298-3306 (2015). |